Home
About
Overview
Sharing Data
ORCID
Help
History (92)
Trio Act of Boronolectin with Antibiotic-Metal Complexed Macromolecules toward Broad-Spectrum Antimicrobial Efficacy.
Tobacco Use Cessation Products
Contingent Negative Variation
Eliminating glutaraldehyde from crosslinked collagen films using supercritical CO2.
Economic analysis during phase III clinical trials: who, what, when, where, and why?
See All 92 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Economic analysis during phase III clinical trials: who, what, when, where, and why?
Economic analysis during phase III clinical trials: who, what, when, where, and why? Oncology (Williston Park). 1995 Nov; 9(11 Suppl):169-75.
View in:
PubMed
subject areas
Clinical Trials, Phase III as Topic
Costs and Cost Analysis
Humans
Neoplasms
authors with profiles
Charles Lee Bennett